Mohamed Shahin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mohamed Shahin has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Jeremiah Sabado
Department of Radiology, Slot 105, Arkansas Children′s Hospital, Little Rock, United States
1 shared publication - Kumar Kempegowda Shashi
Department of Radiology, Arkansas Children’s Hospital, Little Rock, USA
1 shared publication - Raja Shaikh
Department of Radiology, Boston Children's Hospital, Boston, Massachusetts
1 shared publication - Rush H. Chewning
Rady Children′s Hospital-San Diego, San Diego, United States
1 shared publication
Latest Publications
- 10 September 2026
- Published by Springer Nature in Pediatric Radiology
- p. 1-12
Image-guided ablation for pediatric malignant solid tumors: a review of modalities, evidence, and clinical applications
Image-guided percutaneous ablation has evolved into an increasingly utilized approach in selected pediatric oncologic indications. The evidence base remains thinner than clinical adoption would suggest. Most published series are small, retrospective, and limited to single institutional experiences. This review synthesizes evidence from 1995 through early 2025 on radiofrequency ablation (RFA), cryoablation, microwave ablation (MWA), irreversible electroporation (IRE), and electrochemotherapy across malignant solid tumors in patients aged 18 years or younger. Hepatoblastoma has shown the steepest rising incidence among ablation-relevant solid tumors with an annual percent change of +2.17%. Five-year survival for bone tumors and soft tissue sarcomas remains near 60%. For malignant solid tumors, the evidence remains limited to small retrospective series with heterogeneous populations and short follow-up, precluding conclusions about survival benefit. Surgical resection and systemic chemotherapy remain the primary treatment for all malignant solid tumors discussed; ablation is reserved for relapsed, refractory, or surgically limited scenarios. A coordinated multicenter registry with standardized survival endpoints remains the most urgent unmet need in the field. Graphical abstract
- 10 September 2026
- Published by Springer Nature in Pediatric Radiology
- p. 1-12
Image-guided ablation for pediatric malignant solid tumors: a review of modalities, evidence, and clinical applications
Image-guided percutaneous ablation has evolved into an increasingly utilized approach in selected pediatric oncologic indications. The evidence base remains thinner than clinical adoption would suggest. Most published series are small, retrospective, and limited to single institutional experiences. This review synthesizes evidence from 1995 through early 2025 on radiofrequency ablation (RFA), cryoablation, microwave ablation (MWA), irreversible electroporation (IRE), and electrochemotherapy across malignant solid tumors in patients aged 18 years or younger. Hepatoblastoma has shown the steepest rising incidence among ablation-relevant solid tumors with an annual percent change of +2.17%. Five-year survival for bone tumors and soft tissue sarcomas remains near 60%. For malignant solid tumors, the evidence remains limited to small retrospective series with heterogeneous populations and short follow-up, precluding conclusions about survival benefit. Surgical resection and systemic chemotherapy remain the primary treatment for all malignant solid tumors discussed; ablation is reserved for relapsed, refractory, or surgically limited scenarios. A coordinated multicenter registry with standardized survival endpoints remains the most urgent unmet need in the field. Graphical abstract